Lbrown
Sat Dec 17, 2011, 09:51 AM
This is a good article about the use of VDR agonists to treat autoimmune disease: http://onlinelibrary.wiley.com/doi/10.1359/jbmr.07s217/pdf
The treatment I'm on uses olmesartan as the VDR agonist, and you limit your blood levels of vitamin D to reduce the level of the hormone 1,25D (short for 1,25(OH)2D3). It is replaced by olmesartan which binds into the VDR.
When I had my vitamin D measured, my serum vitamin D was low, but my 1,25D (the active metabolite) was high. It is not common to test for 1,25D, which is why very often people have low vitamin D and are considered vitamin D deficient. If they tested for the active metabolite it could show otherwise. The theory is that most people with AI disease seem to be D-deficient, but it is a result of and not the cause of the disease, and is dysregulated in AI disease.
Deb
The treatment I'm on uses olmesartan as the VDR agonist, and you limit your blood levels of vitamin D to reduce the level of the hormone 1,25D (short for 1,25(OH)2D3). It is replaced by olmesartan which binds into the VDR.
When I had my vitamin D measured, my serum vitamin D was low, but my 1,25D (the active metabolite) was high. It is not common to test for 1,25D, which is why very often people have low vitamin D and are considered vitamin D deficient. If they tested for the active metabolite it could show otherwise. The theory is that most people with AI disease seem to be D-deficient, but it is a result of and not the cause of the disease, and is dysregulated in AI disease.
Deb